Haleon plc

Haleon plc is a British multinational consumer healthcare company headquartered in Weybridge, England, specializing in the research, development, manufacture, and sale of everyday health products worldwide, including North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Its portfolio features trusted brands like Sensodyne, Polident, Parodontax, Aquafresh, and Biotene for oral health; Centrum, Emergen-C, and Caltrate for vitamins, minerals, and supplements; and over-the-counter remedies such as Otrivine, Theraflu, Flonase for respiratory relief; Voltaren, Panadol, Advil for pain and inflammation; and TUMS, ENO, Fenistil for digestive and skin issues. Formed as a 2022 spin-off from GSK following a joint venture with Pfizer, Haleon traces its roots to 1715 and focuses exclusively on accessible, science-backed solutions to empower consumers' daily health management, collaborating with health professionals and policymakers. As one of the world's largest consumer healthcare firms, it holds a significant market share in over-the-counter medicines and drives innovation in oral care, pain relief, and nutritional support.